Four target genes (BCL2L1, IGF1R, MAPK8, and FAS) and 5 signaling pathways (PI3K-Akt, FoxO, MAPK, pathways in cancer, and proteoglycans in cancer) were identified. This evidence concerns the gene IGF1R and cancer.